14 4
- Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an
ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann
Rheum Dis. 2009;68(1):18–24 [Validation Studies]. - Aydin SZ, Can M, Atagunduz P, Direskeneli H. Active disease requiring TNF-alpha-antagonist
therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of
disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol. 2010;28(5):752–5
[Validation Studies]. - Nas K, Yildirim K, Cevik R, Karatay S, Erdal A, Baysal O, et al. Discrimination ability of
ASDAS estimating disease activity status in patients with ankylosing spondylitis. Int J Rheum
Dis. 2010;13(3):240–5 [Comparative Study Multicenter Study]. - Pedersen SJ, Sorensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, et al.
Responsiveness of the ankylosing spondylitis disease activity score (ASDAS) and clinical and
MRI measures of disease activity in a 1-year follow-up study of patients with axial spondylo-
arthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis. 2010;69(6):1065–
71 [Multicenter Study Research Support, Non-U.S. Gov’t Validation Studies]. - Kiltz U, van der Heijde D. Health-related quality of life in patients with rheumatoid arthritis
and in patients with ankylosing spondylitis. Clin Exp Rheumatol. 2009;27(4 Suppl 55):S108–
11 [Review]. - Wanders A, Landewe R, Dougados M, Mielants H, van der Linden S, van der Heijde
D. Association between radiographic damage of the spine and spinal mobility for individual
patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radio-
graphic evaluation? Ann Rheum Dis. 2005;64(7):988–94 [Evaluation Studies]. - Machado P, Landewe R, Braun J, Hermann KG, Baker D, van der Heijde D. Both structural
damage and infl ammation of the spine contribute to impairment of spinal mobility in patients
with ankylosing spondylitis. Ann Rheum Dis. 2010;69(8):1465–70. - Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D. Physical function
in ankylosing spondylitis is independently determined by both disease activity and radio-
graphic damage of the spine. Ann Rheum Dis. 2009;68(6):863–7. - Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to
defi ning functional ability in ankylosing spondylitis: the development of the bath ankylosing
spondylitis functional index. J Rheumatol. 1994;21(12):2281–5 [Comparative Study Research
Support, Non-U.S. Gov’t]. - Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a func-
tional index and an articular index in ankylosing spondylitis. J Rheumatol.
1988;15(2):302–7. - Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden
S. Employment, work disability, and work days lost in patients with ankylosing spondylitis: a
cross sectional study of Dutch patients. Ann Rheum Dis. 2001;60(4):353–8. - Sigl T, Cieza A, van der Heijde D, Stucki G. ICF based comparison of disease specifi c instru-
ments measuring physical functional ability in ankylosing spondylitis. Ann Rheum Dis.
2005;64(11):1576–81 [Comparative Study]. - Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development
of the ASQoL: a quality of life instrument specifi c to ankylosing spondylitis. Ann Rheum Dis.
2003;62(1):20–6 [Research Support, Non-U.S. Gov’t]. - Doward LC, McKenna SP, Meads DM, Twiss J, Revicki D, Wong RL, et al. Translation and
validation of non-English versions of the ankylosing spondylitis quality of life (ASQoL) ques-
tionnaire. Health Qual Life Outcomes. 2007;5:7 [Multicenter Study Research Support,
Non-U.S. Gov’t]. - Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a
health index in patients with ankylosing spondylitis (ASAS hi): fi nal result of a global initia-
tive based on the ICF guided by ASAS. Ann Rheum Dis. 2015;74(5):830–5. - Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N,
et al. ASAS/who ICF core sets for ankylosing spondylitis (as): how to classify the impact of as
on functioning and health. Ann Rheum Dis. 2010;69(1):102–7 [Consensus Development
Conference].
U. Kiltz et al.